LDX lumos diagnostics holdings limited

LDX Chart, page-127

  1. 1,067 Posts.
    lightbulb Created with Sketch. 231
    LDX Equity Value before Product Revenue is around 18.6c or $82.6m market cap.

    This is before multiple stream future product revenue and a potential $2.5 billion USD annual healthcare cost saving in America alone if FebriDx was implemented for ARI (Acute Respiratory Infection) cases.

    Giddy Up LDX!!

    2277186_Economic-Evaluation-of-FebriDx.pdf (lumosdiagnostics.com)

    Economic Evaluation of FebriDx®: A Novel Rapid, Point-of-Care Test for Differentiation of Viral versus Bacterial Acute Respiratory Infection in the United States | Published in Journal of Health Economics and Outcomes Research (jheor.org)

    https://hotcopper.com.au/data/attachments/5513/5513284-99992dd34aa5430252a502fe21880836.jpg





 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.7¢
Change
0.000(0.00%)
Mkt cap ! $20.21M
Open High Low Value Volume
2.7¢ 2.7¢ 2.6¢ $24.71K 917.8K

Buyers (Bids)

No. Vol. Price($)
3 274085 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 989898 5
View Market Depth
Last trade - 15.56pm 25/06/2025 (20 minute delay) ?
LDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.